Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.
2.

Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review.

Afshar N, Tabas J, Afshar K, Silbergleit R.

J Hosp Med. 2009 Feb;4(2):112-23. doi: 10.1002/jhm.382. Review.

3.

Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department.

Campbell SG, Marrie TJ, Anstey R, Ackroyd-Stolarz S, Dickinson G.

Emerg Med J. 2003 Nov;20(6):521-3.

4.

Limited usefulness of initial blood cultures in community acquired pneumonia.

Corbo J, Friedman B, Bijur P, Gallagher EJ.

Emerg Med J. 2004 Jul;21(4):446-8.

5.

[Clinical usefulness of blood cultures in hospitalized patients with community-acquired pneumonia].

Díaz A, Calvo M, O'Brien A, Farías G, Mardónez JM, Saldías F.

Rev Med Chil. 2002 Sep;130(9):993-1000. Spanish.

PMID:
12434646
6.

Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

Iroh Tam PY, Bernstein E, Ma X, Ferrieri P.

Hosp Pediatr. 2015 Jun;5(6):324-36. doi: 10.1542/hpeds.2014-0138. Review.

7.
9.

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.

van der Eerden MM, de Graaff CS, Vlaspolder F, Bronsveld W, Jansen HM, Boersma WG.

Clin Ther. 2004 Feb;26(2):294-303.

PMID:
15038952
10.

Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.

Lui G, Ip M, Lee N, Rainer TH, Man SY, Cockram CS, Antonio GE, Ng MH, Chan MH, Chau SS, Mak P, Chan PK, Ahuja AT, Sung JJ, Hui DS.

Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.

PMID:
19818051
11.

Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.

Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ.

Arch Intern Med. 2001 Sep 24;161(17):2099-104.

PMID:
11570938
12.

Low utility of blood culture in pediatric community-acquired pneumonia: An observational study on 2705 patients admitted to the emergency department.

Kwon JH, Kim JH, Lee JY, Kim YJ, Sohn CH, Lim KS, Kim WY.

Medicine (Baltimore). 2017 Jun;96(22):e7028. doi: 10.1097/MD.0000000000007028.

13.

Blood cultures in community-acquired pneumonia: are we ready to quit?

Luna CM.

Chest. 2003 Apr;123(4):977-8. No abstract available.

PMID:
12684278
14.

Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.

Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratalà J.

Medicine (Baltimore). 2011 Mar;90(2):110-8. doi: 10.1097/MD.0b013e318210504c.

15.

Impact of pre-hospital antibiotic use on community-acquired pneumonia.

Simonetti AF, Viasus D, Garcia-Vidal C, Grillo S, Molero L, Dorca J, Carratalà J.

Clin Microbiol Infect. 2014 Sep;20(9):O531-7. doi: 10.1111/1469-0691.12524. Epub 2014 Feb 10.

16.

Do we really need blood cultures in treating patients with community-acquired pneumonia?

Erdede M, Denizbasi A, Onur O, Guneysel O.

Bratisl Lek Listy. 2010;111(5):286-9.

PMID:
20568420
17.

Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: a study on patients treated in a Finnish university hospital.

Hohenthal U, Sipilä J, Vainionpää R, Meurman O, Rantakokko-Jalava K, Nikoskelainen J, Kotilainen P.

Scand J Infect Dis. 2004;36(3):198-203.

PMID:
15119365
18.

Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.

Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman MS, Torres A.

Chest. 2007 Aug;132(2):515-22. Epub 2007 May 15.

PMID:
17505026
19.

Usefulness of initial blood cultures in patients admitted with pneumonia from an emergency department in Japan.

Abe T, Tokuda Y, Ishimatsu S, Birrer RB.

J Infect Chemother. 2009 Jun;15(3):180-6. doi: 10.1007/s10156-009-0682-z. Epub 2009 Jun 25.

PMID:
19554403
20.

Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin.

Zasowski E, Butterfield JM, McNutt LA, Cohen J, Cosler L, Pai MP, Gottwald J, Chen WZ, Lodise TP.

Antimicrob Agents Chemother. 2014 Jul;58(7):3804-13. doi: 10.1128/AAC.02632-13. Epub 2014 Apr 21.

Supplemental Content

Support Center